PNC Financial Services Group’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-65
Closed -$724 5187
2025
Q2
$724 Buy
+65
New +$813 ﹤0.01% 4620

Other funds holding NPCE

PNC Financial Services Group's NPCE Position: Q3 2025 in Review

PNC Financial Services Group sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 65 shares — an estimated $724 sold.

PNC Financial Services Group first reported a position in NPCE in Q2 2025 and held it in 1 quarter. The position peaked at $724 in Q2 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.

  • PNC Financial Services Group reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 65 Neuropace shares in Q3 2025, an estimated $724.
  • PNC Financial Services Group first reported a position in Neuropace in Q2 2025 and held it in 1 quarter.
  • PNC Financial Services Group's Neuropace position peaked at $724 in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.